Mr. James Durward reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) ANNOUNCES A NEW PRESIDENT AND CHIEF PSYCHIATRIC OFFICER

Ndatalyze Corp. has appointed Dr. Keith Courtney to the position of president and chief psychiatric officer. The appointment is effective immediately.

Dr. Courtney is a board-certified psychiatrist who has been practicing since 1995. Dr. Courtney graduated from the Chicago College of Osteopathic Medicine in 1990. He completed his residency in general psychiatry at Louisiana State University in New Orleans and a fellowship in cross-cultural psychiatry at the University of Minnesota. He is board-certified by the American Board of Psychiatry and Neurology and is a fellow of the American Society of Addictions Medicine. He has been on the faculties of Dartmouth University, the University of Vermont, Louisiana State University, and the University of Nevada. He is currently on the faculty of the University of Calgary where he supervises residents and medical students. Dr. Courtney's areas of interest include psychiatric assessment, psychopharmacology, psychotherapy (including psychodynamic psychotherapy, cognitive-behavioural therapy, mindfulness-based therapies, and others), sports and performance arts mental health issues, psychedelic therapies, and complementary and alternative psychiatric interventions. He has a certification in Ketamine-Assisted Psychotherapy from the Integrative Psychiatry Institute and is Medical Director of BLOOM Psychedelic Therapy and Research Institute. Effective immediately, the Company's current President, Jim Durward, will move to the position of Chief Technical Officer ("CTO"),

James Durward, CTO, states: "I am so pleased to have Dr. Courtney as our new President. He has been involved with YMI since the beginning and was instrumental in the mental condition scoring algorithm that guides YMI's supervised-machine-learning predictions. I expect his experience will be an accelerating force for the acceptance of YMI as an advanced predictive mental condition and prescription system and I very much look forward to working with him during our Clinical Study."

About YMI:

YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge towards a fuller understanding of how mental health develops and to improve mental wellbeing. YMI combines machine-learning with a proprietary Reference Database that contains >1200 person's genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle to generate a personalized graphic report predicting an individual's predisposition toward a variety of common mental conditions, both current and forward in time.

We seek Safe Harbor.